Hemostatic Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting hemostatic clinical trials across 6 countries. Studies span Not Applicable, Phase 1. Top locations include Atlanta, Georgia, United States, Bordeaux, France, Camperdown, New South Wales, Australia. Updated daily from ClinicalTrials.gov.


Hemostatic Trials at a Glance

8 actively recruiting trials for hemostatic are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Atlanta, Bordeaux, and Camperdown. Lead sponsors running hemostatic studies include Cukurova University, Ethicon, Inc., and Centre Hospitalier Universitaire de Nīmes.

Browse hemostatic trials by phase

Treatments under study

About Hemostatic Clinical Trials

Looking for clinical trials for Hemostatic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hemostatic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hemostatic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

HemostasisHemostatic Techniques
Ethicon, Inc.108 enrolled7 locationsNCT06664788
Recruiting
Phase 1

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NeoplasmLymphoproliferative DisordersNeoplasms by Histologic Type+11 more
Kelonia Therapeutics, Inc.70 enrolled7 locationsNCT07075185
Recruiting
Not Applicable

Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

Postoperative PainEfficacy of Hemostatic AgentsPartial Pulpotomy
Cukurova University75 enrolled1 locationNCT07058727
Recruiting

Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Hemostatic
IRCCS San Raffaele100 enrolled1 locationNCT05733585
Recruiting
Not Applicable

Quantra Point-of-Care Hemostasis Monitoring

BleedingHemostatic Disorder
The Cleveland Clinic666 enrolled1 locationNCT06328647
Recruiting
Not Applicable

Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study.

Hemostatic DisorderHyperfibrinogenemia
Centre Hospitalier Universitaire de Nīmes6 enrolled1 locationNCT06571552
Recruiting
Not Applicable

Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

HemostasisSpinal FusionHemostatics+1 more
Polyclinique Bordeaux Nord Aquitaine100 enrolled1 locationNCT05323448
Recruiting
Phase 1

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NeoplasmsMultiple MyelomaCardiovascular Diseases+11 more
OriCell Therapeutics Co., Ltd.81 enrolled1 locationNCT06271252